Skip to search boxSkip to navigationSkip to main content

Antiinflammatory effect of dexamethasone and B vitamins in third molar surgery. Randomized clinical trial

Original title: Efecto antinflamatorio de dexametasona y vitaminas B en cirugía de tercer molar. Ensayo clínico aleatorizado
*Corresponding author for this work
  • Universidad Nacional Mayor de San Marcos
    ,
  • ,
  • Universidad Científica del Sur
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

Spanish

Pages from-to (Number of pages)

Pages 69-75 (7 pages)

Journal (Volume, Issue Number)

Revista Espanola de Cirugia Oral y Maxilofacial (Volume 42, Issue 2)

Publication milestones

  • Published - 2020

Publication status

Published - 2020

ISSN

1130-0558

Publication IDs

  • Scopus: 85091827543

Abstract

Objective: To evaluate the antiinflammatory effect of the preoperative administration of the dexamethasone associated with B vitamins in mandibular third molar surgeries. Materials and methods: Experimental study, which consisted of 54 patients aged 18-25 years, who were assigned in two groups: control group was administered dexamethasone 4 mg and the experimental group, the association of dexamethasone 4 mg with vitamins B1, B6, B12; both intramuscularly before surgery. The anti-inflammatory effect was determined by the evaluation of pain and swelling. The pain was evaluated by means of the analogous visual scale, time for rescue analgesia and total analgesic consumption. The swelling was assessed by facial contour measurements. Results: It was demonstrated that the maximum intensity of pain was at 24 hours, being this significantly lower in the experimental group (4.0 vs. 5.8 cm), p<0.05; then the values were gradually decreasing at 48 hours, with the value in the experimental group being significantly lower (3.3 vs. 5.4 cm), p<0.05. The experimental group showed a longer time for rescue analgesia (2.48 vs. 2.08 h), p>0.05; and lower analgesic consumption (8.5 vs. 9.4 tab), p<0.05. The facial swelling increased progressively until the third day, without significant differences between the groups (45.4 vs. 46 cm), p>0.05. Conclusions: There was a significant higher analgesic activity and a significantly lower total analgesic consumption in the experimental group compared to the control group. There were no significant differences in swelling.